BioSpace News Archive

Biotech Beach

Design Therapeutics to Participate in the 2022 Wedbush PacGrow Virtual Healthcare Conference

Design Therapeutics, Inc. announced that João Siffert, M.D., president and chief executive officer, and Sean Jeffries, Ph.D., chief operating officer, will participate in a fireside chat during the 2022 Wedbush PacGrow Virtual Healthcare Conference on Wednesday, August 10, 2022, at 10:20 a.m. ET.

August 3, 2022
·
1 min read
Genetown

Nuvalent to Present at the Canaccord Genuity 42nd Annual Growth Conference

Nuvalent, Inc. announced that James Porter, Ph.D., Chief Executive Officer, will present at the Canaccord Genuity 42nd Annual Growth Conference on Wednesday, August 10, 2022, at 4:00 p.m. ET in Boston.

August 3, 2022
·
1 min read
Business

Editas Medicine Announces Second Quarter 2022 Results and Business Updates

Editas Medicine, Inc., a leading genome editing company, reported business highlights and financial results for the second quarter of 2022.

August 3, 2022
·
12 min read
Joint Reconstruction Devices Market Size Worth USD 36.81 Billion By 2027 | Emergen Research

The global Joint Reconstruction Devices Market is expected to reach USD 36.81 Billion by 2027, according to a new report by Emergen Research.

August 3, 2022
·
6 min read
Business

Corcept Therapeutics Announces Second Quarter 2022 Financial Results and Provides Corporate Update

Corcept Therapeutics Incorporated, a commercial-stage company engaged in the discovery and development of medications to treat severe endocrine, oncologic, metabolic and neurological disorders by modulating the effects of the hormone cortisol, reported its results for the quarter ended June 30, 2022.

August 3, 2022
·
10 min read
Biotech Beach

Inari Medical Announces Leadership Succession Plan

Inari Medical, Inc., a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced that Chief Operating Officer Drew Hykes will succeed Bill Hoffman as Chief Executive Officer, effective January 1, 2023.

August 3, 2022
·
5 min read
Business

Kura Oncology Reports Second Quarter 2022 Financial Results

Kura Oncology, Inc., a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, reported second quarter 2022 financial results and provided a corporate update.

August 3, 2022
·
10 min read
Biotech Beach

Oncocyte to Participate at Upcoming Investor Conferences - Aug 03, 2022

Oncocyte Corporation, a precision diagnostics company with the mission to improve patient outcomes by providing personalized insights that inform critical decisions throughout the patient care journey, announced that its management team will participate at the following conferences.

August 3, 2022
·
1 min read
Business

Anika Reports Second Quarter Fiscal 2022 Financial Results

Anika Therapeutics, Inc., a global joint preservation company in early intervention orthopedics, reported financial results for its second quarter ended June 30, 2022.

August 3, 2022
·
15 min read
Business

Axogen, Inc Reports 2022 Second Quarter Financial Results

Axogen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, reported financial results and business highlights for the second quarter ended June 30, 2022.

August 3, 2022
·
17 min read